Contact Us for Pricing
Initial Consultation
- Assess and understand your immediate needs and questions
- The initial consultation will be focused on gathering information about your current cancer status
We will discuss your medical history including past illnesses, family history and genetic factors related to cancer. In addition, we will collect information about initial and current symptoms, tests that have been performed and results, past and current treatments and response to each treatment. Our aim is to equip you with necessary information to assist you throughout your cancer journey and in conjunction with your oncology team. To accomplish this, we will inquire about your current understanding of your diagnosis and treatment plans, as well as your interest in learning more about all available tests for personalized treatment options, and any concerns you may have regarding the proposed treatment plan. With the initial consultation, we can gather valuable insights, address your immediate concerns, and customize our support and educational efforts to meet your specific needs. Our service will be complementary to your oncology healthcare team.
In-depth review of medical records and cancer status
- Carefully analyze key points from your cancer history, diagnostic test results, and treatment options to reduce any ambiguity.
- Discuss a tailored plan with recommendations to support the cancer journey, including quality of life, genomic testing/imaging and treatment options.
In-depth review of medical records and cancer status
Our goal is to support you during this time with relevant information. To address this, we will request you to share all relevant medical records. We understand sometimes it is difficult to obtain records, but our experts will discuss with you any relevant information that you have. If available, once we receive your records, our subject matter experts will conduct a thorough analysis. We will delve into the specifics of your cancer history, diagnosis, the primary tumor type, current status- grade and stage, and all test results, including genomics test results. In addition, we will review previous treatments and interventions you have undergone, and their outcome, which may help to understand the tumor behavior. This will assist in identifying factors related to tumor response or resistance to different treatment options, as it can vary based on individual cases, cancer type, disease stages and more. This thorough evaluation will help us to create an individualized plan to support important discussions for you to have with your oncology team based on your medical history and your ever changing needs. Here is a general overview of the major factors we will focus on:
Successful Treatment Response:
Evidence of tumor shrinkage or disappearance after treatment.
Absence of cancer cells in post-treatment scans or tests.
Stable Disease:
The cancer remains stable, neither progressing nor regressing.
No new lesions or growth observed in follow-up scans.
Well-Tolerated Treatment:
Tolerated treatment with minimal side effects.
Maintenance of overall health and quality of life during treatment.
Normalization of Biomarkers:
Tumor driving markers return to normal levels.
Targetable tumor biomarkers show a positive response to treatment.
Good Performance Status:
A good level of physical activity and daily functioning.
Positive indicators of overall well-being and ability to engage in usual activities.
Alternatively, certain factors may need Parthen support for consideration or adjustment. This could involve challenges, unresolved issues, or aspects of your health that require additional attention or a modified approach.
Disease Progression:
Evidence of tumor growth or spread to new areas.
Worsening of symptoms or development of new symptoms.
Treatment Resistance:
Lack of response or resistance to current treatment.
Persistence or recurrence of cancer despite therapy.
Adverse Treatment Effects:
Adverse events or complications from treatment and/or co-medications.
Deterioration in overall health due to the treatment regimen.
Elevated Biomarkers:
Persistent or increasing levels of tumor markers or other specific indicators.
Tumors with targetable markers can develop resistance to targeted therapy if tumor acquires certain co-mutations
Decline in Performance Status:
Decreased ability to perform daily activities.
Decline in overall physical well-being and functionality.
During the above process, we encourage open communication. You can feel free to share your thoughts, concerns, and preferences. Your active participation ensures that our recommendations align with your needs and aspirations.
Provide you with the knowledge to communicate with your oncology team
- Assist you to engage effectively with your oncology team and discuss all major aspects to align with your needs and address any challenges.
- Constantly support your communication with the oncology team by providing essential, timely knowledge about your cancer journey, including clinical uncertainties.
Sometimes you don’t know what questions should be asked. We provide you with the knowledge to communicate with your oncology team to reach your best outcome.
It is important for you and your family members to engage with your primary oncology team effectively. Consistent and effective communication enables you to advocate for your health and request additional required diagnostic tests, consistent monitoring and possible treatment options. Fostering an open communication will help you to understand and address major aspects of the cancer journey:
Thorough understanding about diagnostic tests and its results.
Diagnostic tests play a pivotal role in the cancer path, guiding treatment decisions, and assessing treatment effectiveness. We will carefully explain the purpose of each test, potential outcomes, and how the results contribute to tailoring a personalized and effective treatment plan for you.
Potential benefits and risks of treatment options.
No two cancer journeys are identical. Understanding various treatment options can enable you to actively participate in decisions regarding your care. Our team will gather information about the available treatment modalities, potential side effects, and anticipated outcomes.
There can be certain clinical uncertainties in any phase of the cancer journey. The primary oncology team may encounter similar options related to diagnosis and treatment response due to the complexity of cancer and offer you choices. Parthen wil have open communication about any uncertainties that may allow you to navigate your journey with realistic expectations. Implementing these actions will enable you to actively participate in decisions related to diagnostic tests and treatment options.
Dedicated Sessions: Your Guided Path
- In these sessions you can openly discuss your concerns, ask questions, and share your thoughts.
- We will provide clarity on medical updates and potential treatment plans by discussing the “pros” and “cons” of your various options, including matched clinical trials.
Dedicated Sessions: Your Guided Path
The patient journey sessions at Parthen are not just about managing the medical aspects; they are about supporting the entirety of your well-being. Your voice matters, and together, we navigate the path to your best possible outcomes.
Our dedicated sessions are crafted to address the unique aspects of your cancer journey. Based on the status, it may be related to one or more of the following: diagnosis, treatment, medical updates, emotional well-being, and personalized guidance. In these sessions you can openly discuss your concerns, ask questions, and share your thoughts. We will provide clarity on medical updates, treatment plans, and practical aspects.
For details on upcoming sessions or to schedule a personalized consultation, please contact us.
On-demand expertise
